Browsing by Author Chim, Lesley

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2010Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?Chim, Lesley; Kelly, Patrick John; Salkeld, Glenn; Stockler, Martin; School of Public Health: Public Health; School of Public Health: Medicine; School of Public Health: Public Health; NH&MRC Clinical Trials CentreAre Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?, PharmacoEconomics, vol.28, 6, 2010,pp 463-475
2017Is it all about price? Why requests for government subsidy of anticancer drugs were rejected in AustraliaChim, Lesley; Howard, Kirsten; Karikios, Deme; Martin, Andrew; Nagrial, Adnan; Stockler, Martin; Salkeld, G; School of Public Health: Public Health; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); NH&MRC Clinical Trials CentreIs it all about price? Why requests for government subsidy of anticancer drugs were rejected in Australia, Internal Medicine Journal, vol.47, 4, 2017,pp 400-407
2017Societal perspective on access to publicly subsidised medicines: A cross sectional survey of 3080 adults in AustraliaChim, Lesley; Kelly, Patrick John; Lipworth, Wendy; Stockler, Martin; Hughes, D; Salkeld, G; School of Public Health: Public Health; School of Public Health: Medicine; School of Public Health: Ctr for Values Ethics & Law in Med; NH&MRC Clinical Trials CentreSocietal perspective on access to publicly subsidised medicines: A cross sectional survey of 3080 adults in Australia, PloS One, vol.12, 3, 2017,pp 1-24
2015Weighing up the benefits and harms of a new anti-cancer drug - a survey of Australian oncologistsChim, Lesley; Salkeld, Glenn; Stockler, Martin; Mileshkin, Linda; School of Public Health: Public Health; School of Public Health: Public Health; NH&MRC Clinical Trials CentreWeighing up the benefits and harms of a new anti-cancer drug - a survey of Australian oncologists, Internal Medicine Journal, vol.45, 8, 2015,pp 834-842